EUVIMEDEUVIMED entdecken
Open Access

Novel 1,2,4-triazoles as selective carbonic anhydrase inhibitors showing ancillary anticathepsin B activity

Amit Kumar iD, Priyanka Arya, Simone Giovannuzzi, Brij Mohan, Neera Raghav, Claudiu T Supuran iD, Pawan K Sharma iD

Future Medicinal Chemistry · 2024

DOI: 10.4155/fmc-2023-0321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Amit Kumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Kurukshetra University, Kurukshetra, Haryana, 136119, India. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Triazoles, Cathepsin B. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Human Resource Development Group, DST-FIST.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Exploration of the multi-target approach considering both human carbonic anhydrase (hCA) IX and XII and cathepsin B is a promising strategy to target cancer. Methodology & Results: 22 novel 1,2,4-triazole derivatives were synthesized and evaluated for their inhibition efficacy against hCA I, II, IX, XII isoforms and cathepsin B. The compounds demonstrated effective inhibition against hCA IX and/or XII isoforms with considerable selectivity over off-target hCA I/II. All compounds presented significant anticathepsin B activities at a low concentration of 10-7 M and in vitro results were also supported by the molecular modeling studies.

Conclusion

Insights of present study can be utilized in the rational design of effective and selective hCA IX and XII inhibitors capable of inhibiting cathepsin B. [Box: see text].

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase InhibitorsTriazolesCathepsin BHumansStructure-Activity RelationshipCarbonic AnhydrasesMolecular StructureMolecular Docking SimulationModels, Molecular

Stichwörter der Autor:innen

1,2,4-triazolebenzenesulfonamidecancercarbonic anhydrase inhibitorscathepsin B inhibitorstail-approach

Substanzen

Carbonic Anhydrase InhibitorsTriazolesCathepsin B1,2,4-triazoleCarbonic Anhydrases

Autor:innen und Institutionen

  • Department of Chemistry, Kurukshetra University, Kurukshetra, Haryana, 136119, India.
  • Neurofarba Department, Pharmaceutical & Nutraceutical Section, University of Florence, Florence, 50139, Italy.
  • Centro de Química Estrutural, Institute of Molecular Sciences, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, Lisboa, 1049-001, Portugal.
  • Department of Chemistry, Central University of Haryana, Mahendergarh, Haryana, 123031, India.

ORCID-Profile: Amit Kumar, Claudiu T Supuran, Pawan K Sharma

Förderung

  • Human Resource Development Group
  • DST-FIST

Zitieren

APA

Kumar, A., Arya, P., Giovannuzzi, S., Mohan, B., Raghav, N., Supuran, C. T., & Sharma, P. K. (2024). Novel 1,2,4-triazoles as selective carbonic anhydrase inhibitors showing ancillary anticathepsin B activity. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2023-0321

Vancouver

Kumar A, Arya P, Giovannuzzi S, Mohan B, Raghav N, Supuran CT, et al. Novel 1,2,4-triazoles as selective carbonic anhydrase inhibitors showing ancillary anticathepsin B activity. Future Medicinal Chemistry. 2024. doi:10.4155/fmc-2023-0321

BibTeX
@article{Kumar2024,
  author = {Kumar, Amit and Arya, Priyanka and Giovannuzzi, Simone and Mohan, Brij and Raghav, Neera and Supuran, Claudiu T and Sharma, Pawan K},
  title = {Novel 1,2,4-triazoles as selective carbonic anhydrase inhibitors showing ancillary anticathepsin B activity},
  journal = {Future Medicinal Chemistry},
  year = {2024},
  doi = {10.4155/fmc-2023-0321}
}
Kostenlos starten →